Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CASR | P41180 | 1/20 | 0.41 |
| ▸ | CMA1 | P23946 | 1/20 | 0.41 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11776742 | 0.86 | EPAS1 (0.41) | TSHRPOLBMAPK1FFAR4LMNA | |
| SCHEMBL2618025 | 0.85 | LMNA (0.59) | TSHRPOLBMAPK1LMNAALDH1A1 | |
| SCHEMBL3493614 | 0.84 | MAPK1 (0.70) | TSHRPOLBMAPK1FFAR4LMNA | |
| SCHEMBL29362862 | 0.84 | MAPK1 (0.70) | TSHRPOLBMAPK1FFAR4LMNA | |
| SCHEMBL10497681 | 0.83 | LMNA (0.58) | TSHRPOLBMAPK1LMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL27568289 | 0.82 | MAPK1 (0.68) | TSHRPOLBMAPK1FFAR4LMNA | |
| Ammonia Solution, Strong SCHEMBL9646716 | 0.82 | MAPK1 (0.68) | TSHRPOLBMAPK1FFAR4LMNA | |
| SCHEMBL12180600 | 0.82 | SMN1; SMN2 (0.61) | TSHRPOLBMAPK1FFAR4LMNA | |
| SCHEMBL27996488 | 0.82 | MAPK1 (0.68) | TSHRPOLBMAPK1FFAR4LMNA | |
| SCHEMBL10497763 | 0.82 | MAPK1 (0.68) | TSHRPOLBMAPK1FFAR4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118047979-B | Flame-resistant odorless nano phenolic board and preparation method thereof | 江苏苍古建筑工程有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119320513-A | Flame-resistant odorless nano phenolic plate | 江苏苍古建筑工程有限公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-118047979-A | Flame-resistant odorless nano phenolic board and preparation method thereof | 江苏苍古建筑工程有限公司 | 2024-05-17 | — | — | CN | disclosed |
| EP-3359620-B1 | METHOD OF MONITORING A PARAMETER OF A HYDROCARBON WELL, PIPELINE OR FORMATION | JOHNSON MATTHEY PLC (GB) | 2022-11-30 | — | — | EP | disclosed |
| CN-108303851-B | Photoetching compositions comprising poly(4-hydroxystyrene) class oxetane resin as film-forming resin | 湖北固润科技股份有限公司 | 2019-09-10 | — | — | CN | disclosed |
| US-10365262-B2 | Method of monitoring a parameter of a hydrocarbon well, pipeline or formation | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2019-07-30 | — | — | US | disclosed |
| CN-107074874-B | ERK inhibitor | 伊莱利利公司 | 2019-04-23 | — | — | CN | disclosed |
| CN-108864330-A | Poly(4-hydroxystyrene) class oxetane resin, its synthesis and application | 湖北固润科技股份有限公司 | 2018-11-23 | — | — | CN | disclosed |
| US-20180284096-A1 | METHOD OF MONITORING A PARAMETER OF A HYDROCARBON WELL, PIPELINE OR FORMATION | TRACERCO LIMITED (GB) | 2018-10-04 | — | — | US | disclosed |
| CN-108303851-A | Include photoetching compositions of the poly(4-hydroxystyrene) class oxetane resin as film-forming resin | 湖北固润科技股份有限公司 | 2018-07-20 | — | — | CN | disclosed |
| US-20070181034-A1 | Dye sets for inkjet imaging and ink sets using the same | ETHICON ENDO-SURGERY, INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070176991-A1 | Ink composition and recording method using the same | FUJIFILM CORPORATION (JP) | 2007-08-02 | — | — | US | disclosed |
| US-20070176991-A1 | Ink composition and recording method using the same | FUJIFILM CORPORATION (JP) | 2007-08-02 | — | — | US | disclosed |
| US-20070173641-A1 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | FUJI PHOTO FILM CO., LTD. | 2007-07-26 | — | — | US | disclosed |
| US-20070173641-A1 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | FUJI PHOTO FILM CO., LTD. | 2007-07-26 | — | — | US | disclosed |
| US-7223453-B2 | Ink jet recording medium and ink jet recording method | FUJIFILM CORPORATION (JP) | 2007-05-29 | — | — | US | disclosed |
| US-7223453-B2 | Ink jet recording medium and ink jet recording method | FUJIFILM CORPORATION (JP) | 2007-05-29 | — | — | US | disclosed |
| CN-1956954-A | Novel androgens | ORGANON NV (NL) | 2007-05-02 | — | — | CN | disclosed |
| US-7211132-B2 | Ink set | SEIKO EPSON CORPORATION (JP) | 2007-05-01 | — | — | US | disclosed |
| US-7211132-B2 | Ink set | SEIKO EPSON CORPORATION (JP) | 2007-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173641-A1 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | CYP4A11, CYP4F11, CYP4X1 | TSHR 4796/4885POLB 2936/4885MAPK1 834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.